OPTIMIZE

A Phase II Study of Reduced Dose Post Transplantation Cyclophosphamide as GvHD Prophylaxis in Adult Patients With Hematologic Malignancies Receiving HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Near Add Your Location

Sorting 34 by

Center of Excellence

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients

Center of Excellence

Mayo Clinic (Jacksonville)
Jacksonville, FL
  • Accepting patients

Center of Excellence

Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Accepting patients

Center of Excellence

Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients

Center of Excellence

Barbara Ann Karmanos Cancer Institute
Wayne State University
Detroit, MI
  • Accepting patients

Center of Excellence

Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
  • Accepting patients
Oregon Health and Science University
OHSU Knight Cancer Institute
Portland, OR
  • Accepting patients
UVA Cancer Center
University of Virginia Health System
Charlottesville, VA
  • Accepting patients
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients

Center of Excellence

Fred Hutchinson Cancer Research Center
University of Washington Cancer Consortium / SCCA
Seattle, WA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.